Transforming Growth Factor-β in Cancer Therapy, Volume II Cancer Treatment and Therapy /
Transforming Growth Factor-ß in Cancer Therapy, Volumes 1 and 2, provides a compendium of findings about the role of transforming growth factor-ß (TGF-ß) in cancer treatment and therapy. The second volume, Cancer Treatment and Therapy, is divided into three parts. Part I examines transforming growth...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Totowa, NJ :
Humana Press,
2008.
|
| Σειρά: | Cancer Drug Discovery and Development
|
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Transforming Growth Factor-? In Developing and Advanced Cancers
- Transforming Growth Factor-? Signaling in Pancreas Development and Pancreatic Disease
- Role of Transforming Growth Factor-? in the Pathogenesis of Human Head and Neck Squamous Cell Carcinoma
- TGF-?, Smads and Cervical Cancer
- TGF-? Signaling and Biglycan in Pancreatic Cancer
- TGF-? Signaling in Endometrial Cancer
- TGF-? Ligands, TGF-? Receptors, and Lung Cancer
- Role of TGF-? in Osteolytic Bone Metastases
- Hormonal Regulation of Transforming Growth Factor-? in Breast Cancer
- TGF-? and Progression of Esophageal Cancer
- TGF-? and HER2/ErbB2 and Breast Cancer Progression
- TGF-? Dependent T-Cell Regulation in Colitis and Colon Cancer
- Role of Transforming Growth Factor-? in the Kidney — Physiology and Pathology
- Perturbations of TGF-? Signaling in Leukocytes as Drivers of Leukemogenesis and Epithelial Tumorigenesis
- Transforming Growth Factor-? in Brain Functions and Dysfunctions
- Inhibition of TGF-? Signaling in Multiple Myeloma and Its Bone Marrow Microenvironment
- Key Roles of TGF-? and Smad3 in Prostate Cancer
- Smad Signaling in Leukemic Growth and Differentiation: Crosstalk Between Smad and Multiple Pathways Through Activation of the TGF-? Type I Receptor
- Transforming Growth Factor-? in Cancer Treatment and Therapy
- High-Throughput Screening of Protein Interaction Networks in the TGF? Interactome: Understanding the Signaling Mechanisms Driving Tumor Progression
- Tumor Suppressor and Pro-progression Roles for TGF-? in Breast Cancer
- Tumor Suppressors p53 and TGF? Converge to Regulate the Alpha-Fetoprotein Oncodevelopmental Tumor Marker
- TGF?: Roles in DNA Damage Responses
- The Rationale for and Effects of Targeting TGF-? for Glioma Therapy
- Tumor Suppressor Functions of TGF?1 in T Cells
- Therapeutic Effects of Adenovirus-Mediated Gene Transfer of TGF-? Signal Antagonists on Undesirable Epithelial-Mesenchymal Transition and Neovascularization
- Role of TGF-? in Tumor Protection and Antitumor Immunity
- Regulation of Angiogenesis and Tumor Growth by Thrombospondin-1
- Cancer-Associated Fibroblasts and the Role of TGF-?
- Adoptive Transfer of Tumor Reactive TGF-? Insensitive CD8+ T-cells for Cancer Therapy
- DNA Methylation and Histone Deacetylation Inhibitors as Potential Therapeutic Agents for the Reconstitution of TGF-? Signaling in Breast Cancer
- Reactive Stroma and Evolution of Tumors: Integration of Transforming Growth Factor-?, Connective Tissue Growth Factor, and Fibroblast Growth Factor-2 Activities
- TGF-? Signaling and Vascular Morphogenesis
- Aberrant Transforming Growth Factor-? Signaling in Human Pancreatic Cancer: Translational Implications
- TGF-? and Stromal Influences Over Local Tumor Invasion
- TGF-? at the Crossroads Between Inflammation, Suppression and Cancer
- Development of Inhibitors of Transforming Growth Factor-? Signaling for Therapy
- Transforming Growth Factor-? (TGF-?) Signaling Inhibitors in Cancer Therapy
- Targeting TGF-? as a Strategy to Ameliorate Intestinal Side Effects of Radiation Therapy
- Targeting Transforming Growth Factor-? in Metastasis: In Vitro and In Vivo Mechanisms
- Targeted Downregulation of TGF-?2 with AP 12009 in Tumor Therapy
- Modulating TGF-? Receptor Signaling: A Novel Approach of Cancer Therapy
- Engineering TGF-? Traps: Artificially Dimerized Receptor Ectodomains as High-affinity Blockers of TGF-? Action
- The Use of Virtual Screening in ALK5 Kinase Inhibitor Discovery and Validation of Orally Active ALK5 Kinase Inhibitors in Oncology
- Soluble Type II Transforming Growth Factor-? Receptor Inhibits Tumorigenesis by Augmenting Host Antitumor Immunity
- Reversal of EMT by Small-Molecule Inhibitors of TGF-? Type I and II Receptors: Implications for Carcinoma Treatment
- Soluble TGF-? Type III Receptor Suppresses Malignant Progression of Human Cancer Cells
- Targeting Smad-Dependent TGF-? Signaling with Peptide Aptamers
- Rationale for Anti-TGF-? Antibody Therapy in Oncology.
